Overview

Study of Nivolumab in Combination w Radium-223 in Men w Metastatic Castration Resistant Prostate Cancer

Status:
Recruiting
Trial end date:
2024-06-15
Target enrollment:
Participant gender:
Summary
This is an open label, prospective, trial that begins with a phase Ib safety run-in followed by a phase II expansion cohort.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Utah
Treatments:
Nivolumab